|
Product Name: | PTC299 | Synonyms: | (4-chlorophenyl) 6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate;2H-Pyrido[3,4-b]indole-2-carboxylic acid, 6-chloro-1,3,4,9-tetrahydro-1-(4-methoxyphenyl)-, 4-chlorophenyl ester, (1S)-;(4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1;4-b]indole-2-carboxylate;9-tetrahydropyrido[3;Emvododstat;Emvododstat (PTC299);(4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate | CAS: | 1256565-36-2 | MF: | C25H20Cl2N2O3 | MW: | 467.34 | EINECS: | | Product Categories: | | Mol File: | 1256565-36-2.mol | ![PTC299 Structure](CAS/20200611/GIF/1256565-36-2.gif) |
| PTC299 Chemical Properties |
Boiling point | 643.4±55.0 °C(Predicted) | density | 1.395±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO : 50 mg/mL (106.99 mM; Need ultrasonic) | form | A solid | pka | 16.08±0.40(Predicted) |
| PTC299 Usage And Synthesis |
Uses | PTC 299 is used for treating acute myeloid leukemia and neurofibromatosis. |
| PTC299 Preparation Products And Raw materials |
|